News

According to Research by SNS Insider, U.S. Multiple Myeloma Market is projected to reach USD 13.91 Billion by 2032, as novel drug classes, immunotherapies, and diagnostic advances reshape treatment ...
Novel drug regimens, autologous stem cell transplant (ASCT), and modern supportive care are prolonging remission, improving ...
A comprehensive US analysis showed that progress in multiple myeloma survival has not been shared equally, with significant disparities persisting despite improved therapies.
Multiple myeloma is predominantly a disease of the elderly, with the median age at diagnosis about 70; one-third of patients are older than 75, and 10% are older than 80. Along with this worldwide ...
Patients have been asking me about a recently published article that suggests a "'potential cure"' for myeloma is at hand.
Survival of patients with multiple myeloma (MM), including those who are high-risk or elderly, has continued to improve, according to an abstract presented at the 2019 annual meeting of the ...
Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study can help patients and ...
Findings from a retrospective clinical study of 5,383 patients with multiple myeloma, 15% of which had diabetes (12% White and 25% Black), published in the journal Blood Advances, showed survival to ...
Multiple myeloma is relatively rare; in the U.S., the lifetime risk of getting this type of cancer is 1 in 143, and the disease causes less than 13,000 deaths each year, according to the American ...
Researchers have found that multiple myeloma patients with a genetic variation in the gene FOPNL die on average 1-3 years sooner than patients without it. The finding was identified with a genetic ...
Overall survival and event-free survival were compared between the groups after a median follow-up of 88.4 months. In the entire group, overall survival was 47.1% at five years and 33.4% at 10 years.
However with this form of multiple myeloma, “Everything is multiplied, the kidneys get bombarded and the tubules get clogged,” Singh says. You can see the protein deposits in a biopsy, he adds.